DXVX: insider trades · South Korea · DART (FSS) DART:dxvx KR KR · DART (FSS) Mcap 167.8Bn€ Healthcare
Discover the full directors' dealings record of DXVX, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, DXVX has recorded 8 reports. Market capitalisation: €167.8bn. The latest transaction was disclosed on 13 May 2026 — Purchase. Among the most active insiders: 임종윤. Every trade is accessible without an account.
Financial data FY ended December 2025 · cache
Income statement
Revenue 29.36 Bn€
Gross profit 3.32 Bn€ 11% margin
Net income −29.04 Bn€ -64.9% margin
Balance sheet & cash
Market cap 167.84 Bn€
Total debt 47.99 Bn€
Free Cash Flow −20.27 Bn€
Debt / Equity 50%
Profitability & ownership
ROE -9.6%
ROA -6.0%
% insiders 61.5%
% institutions 0.0%
Last declaration on 13 May 2026
Declarations 8 total
Executives ● Purchase32 DART
€16,277 6,933 shares @ €2.3477 0.0000% mcap 100.0% of flow
DART:20260513000856 · 1 Aug 2025
Ideal exit: 28 Apr 2026 (T+270) Executives ● Purchase4 DART
€14,897 6,933 shares
DART:20260513000842 · 13 May 2026
Ideal exit: 7 Feb 2027 (T+270) Executives ● Purchase4 DART
€3,812 1,333 shares
DART:20260410003326 · 10 Apr 2026
Ideal exit: 5 Jan 2027 (T+270) Executives ● Purchase17 DART
€2,967 1,333 shares @ €2.967 0.0000% mcap 100.0% of flow
DART:20260410003342 · 31 Mar 2026
Ideal exit: 26 Dec 2026 (T+270) Executives ● Purchase17 DART
€570,405 198,578 shares @ €2.8724 0.0003% mcap 100.0% of flow
DART:20260407000139 · 2 Apr 2026
Ideal exit: 28 Dec 2026 (T+270) Executives ● Purchase9 DART
DART:20260407000196 · 7 Apr 2026
Ideal exit: 2 Jan 2027 (T+270) Executives ● Purchase4 DART
€670,663 253,578 shares
DART:20260407000104 · 7 Apr 2026
Ideal exit: 2 Jan 2027 (T+270) Executives ● Other0 DART
DART:20260313001275 · 13 Mar 2026 details not loaded